INDP Stock: Indaptus Therapeutics, Inc. Stock Price, Analysis & Insights
Get live indp stock price $2.65, comprehensive Indaptus Therapeutics, Inc. stock analysis, charts, news, and expert forecast. Real-time indp stock data and investment insights.
Loading chart...
Company Overview
Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B virus and human immunodeficiency virus infection, which is in Phase I clinical trial. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. was incorporated in 2021 and is headquartered in New York, New York.
Company Information
- CEO
- Jeffrey A. Meckler
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 7
Contact Information
- Website
- https://indaptusrx.com
- Address
- 3 Columbus Circle
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
Business Model & Strategy
Indaptus Therapeutics, Inc. operates in the Biotechnology industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Jeffrey A. Meckler, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Biotechnology model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Indaptus Therapeutics, Inc. competes in the Biotechnology within the broader Healthcare. With 4.6 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Capital Market, Indaptus Therapeutics, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Indaptus Therapeutics, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Indaptus Therapeutics, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Indaptus Therapeutics, Inc.
- ⚠Investors should consider how Indaptus Therapeutics, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
4.64M
P/E Ratio
-0.09
Beta
1.04
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 4.64M market capitalization
- Trading Volume: 27.99M shares traded today
- Price Range: 52-week range of $1.65 - $47.60
- Exchange: Listed on NASDAQ Capital Market
Financial Metrics
Market Analysis for Indaptus Therapeutics, Inc.
Indaptus Therapeutics, Inc. (INDP) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 4.64M, the company represents a significant player in its market. The stock is currently trading at $2.65 with a positivedaily change of 35.90%.
The company's 7 employee base and presence on the NASDAQ Capital Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -0.09, beta of 1.04, and 52-week price range from $1.65 to $47.60when evaluating investment opportunities.
Why Invest in Indaptus Therapeutics, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Capital Market)
- • Experienced leadership under Jeffrey A. Meckler
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.